Trusted Products and Expertise
Pharmgate’s product portfolio represents more than choices. Our team provides the technical expertise to choose the right product for the right reason and get the results you want.
Investing in Products for Your Protocols
Pharmgate FDA- and USDA-approved manufacturing sites are undergoing multi-million-dollar expansions to satisfy increasing global customer demand. To serve you better, Pharmgate continuously invests in additional registrations and use claims for livestock and poultry products. Post-approval, we engage industry expertise to conduct contract applied research and commercial evaluation trials.
Pharmgate’s secure and verified supply chain, and innovative go-to-market collaborations, deliver reliable, value-driven core products that meet your protocol requirements.
Our technical service and field teams have the production experience to provide practical recommendations in protocol development and implementation.
A Portfolio That Fits Your Protocols
Today’s health protocols require the flexibility to meet evolving disease challenges as well as caregivers’ ability to implement them. By offering multiple options for active ingredients, concentrations, administration routes, and monovalent/bivalent vaccines, Pharmgate’s comprehensive portfolio provides you choices to fit your needs.
Pharmgate is Founded
Partnered with ECO Animal Health
to make Aivlosin® available in US and Canadian markets for ileitis treatment and control.
Acquired Pennfield Animal Health
and its portfolio of water-soluble medication and medicated article (MA) products.
Acquired ADM's Chlortetracycline (CTC) products
Aivlosin® WSG approved for SRD control
Acquired ProtaTek International
a biologics company with a portfolio including: MycoGard®, CircoGard®, CircoMycoGard®.
Launched Deracin® CTC MA
a unique MLV PRRS vaccine approved by US CVB.
Pennitracin MD & Maxiban™ combination approved
Multiple international vaccine approvals
ZoaShield™ 25% approved
Aivlosin® WSG approved for MHP control
Joined with Virbac
to introduce Tulissin®-25, Tulissin® 100, Tia12.5® Tenotryl®
Pennitracin MD & Coban™ combination approved
approved for the prevention of mortality by necrotic enteritis.
Pennchlor® and Rumensin® combinations approved
Aivlosin® WSG Sow restriction removed
and Pennchlor® Rumensin Supplemental Claims approved.